In the interest of keeping at the forefront of modern bioresearch, the University of Illinois Chicago has just announced the construction of a cell regeneration research center at its College of Medicine at Rockford. If the topic of cell regeneration sounds familiar, recall that the Mayo Clinic in Rochester is also a pioneer in regenerative medicine. (You can read our blog on the subject here.) The motivation for the center began with a three million dollar grant from the CWB foundation, which supports projects that benefit disabled people. Thanks to this grant and matching university funds, UIC will be able to join the biotechnology leaders who are performing research in this quickly growing field.
Tags: 2014, Midwest, 2013, University of Illinois, Illinois, BioResearch Product Faire Event, Chicago, IL, UIChgo
Algae research is a well-funded subject for science researchers, especially at Ohio State University. According to The Columbus Dispatch, Ohio State University has received $8.7 million in federal funding for algae-related projects. The U.S. Department of Energy gave $7 million to researchers interested in using waste water to grow algae biofuels, while the National Science Foundation gave $1.5 million for a project concerned with discovering the environmental impact of hazardous algae on Lake Erie. The project researchers are specifically interested in algae’s effects on climate change. Ohio State University researchers also received $150,000 from the Ohio Sea Grant Program to study the liver toxin concentrations on Lake Erie due to blue-green algae.
Tags: 2014, Midwest, 2013, Ohio State University, BioResearch Product Faire Event, Research Funding, NIH, science researchers, Columbus, OH, NSF, lab suppliers, OhStu, Algea
The Knight Cancer Institute at Oregon Health & Science University (OHSU) in Portland has just announced an important partnership with San Diego-based bioprinting technology company Organovo. Research into the biology of cancer, especially how it metastasizes, has been complicated in the past by the limitations of animal models and cell cultures, which really don't tell us enough about the workings of cancer within a human being. Organovo creates living, 3-D human tissue using their bioprinting device, the NovoGen MMX (below). The partnership between OHSU and Organovo will allow cancer research at Knight Institute labs to much more closely model the complex architecture of malignancy within the human body, using in vitro tissue. Ultimately this will lead to the development of more accurate therapeutics and pre-clinical trials.
Tags: 2014, 2013, Oregon Health Sciences University, Oregon Health and Science University, Northwest, cancer research, Oregon, Cancer Treatment, bioprinting, BioResearch Product Faire Event, Funding, Front Line event, OR, OHSU, Portland, Northwest Region
The University of Michigan at Ann Arbor is one of the most richly funded markets in the country for biotechnology vendors and lab suppliers, as recent NIH and NSF research funding statistics show. In 2012, the NIH gave the University of Michigan $456.3 million in research funding. The money has been awarded to various departments for research projects including:
Tags: University of Michigan, 2014, Midwest, 2013, Michigan, Ann Arbor, BioResearch Product Faire Event, Research Funding, Biotechnology, MI, lab supplies, NIH, UMich, NSF, U-M
“It’s pulsing; it’s beating! Now THAT is cool.”
Tags: 2014, Midwest, 2013, Regenerative Medicine, Minnesota, Rochester, Mayo Clinic, BioResearch Product Faire Event, Funding, MN, lab supplier, RMN
Longwood Medical Area is known as one of the most prestigious educational, medical and research areas in the United States. Located along Longwood Avenue in Boston, Massachusetts, Longwood Medical Area (LMA) is made up of teaching hospitals, medical facilities, and non-medical facilities; as well as some top educational institutes, such as Harvard Medical School.
Tags: 2014, Harvard University, 2013, Northeast, Longwood Medical Center, Boston, BioResearch Product Faire Event, Research, MA, Harvard, NIH funding
Biotechnology vendors and lab suppliers in Illinois will find a well-funded market of science researchers at the University of Illinois Urbana-Champaign, according to recent NIH and NSF funding statistics. In 2012, the NIH awarded the university $69.7 million in research funding. Of the different bio departments at the University of Illinois Urbana-Champaign, the money was distributed as follows:
Tags: 2014, Midwest, 2013, University of Illinois, Urbana-Champaign, UIUrbana, BioResearch Product Faire Event, Funding, Research Funding, NIH, IL, science researchers, NSF, lab supplier
In order for HIV to proliferate and infect new cells in the body, a number of proteins need to interact with each other in just the right way. If they don't, the virus is not able to multiply and spread, and HIV infection cannot develop into full-blown Auto Immune Deficiency Syndrome (AIDS). It's a case of finding a weak link and exploiting its potential to disrupt an entire supply chain. In the University of Pittsburgh microbiology lab of Dr. Thomas Smithgall, this protein sabotage approach has successfully allowed them to identify a helper molecule that, if compromised, could form the basis of an effective new HIV/AIDS treatment therapy. The paper documenting their research appeared in the January 24 issue of Chemistry & Biology.
Tags: 2014, 2013, University of Pittsburgh, Pennsylvania, Northeast, AIDS Research, Microbiology, UPITT, BioResearch Product Faire Event, PA, Pittsburgh
In the game of life, cheating doesn’t pay off. Laws, karma, and conscience all work towards keeping things just and fair. However, in the world of bacteria, these rules don’t seem to apply. Researchers from the Washington University at St. Louis have reported a strain of amoeba that favors selfishness over fairness, and doesn’t seem to even pay a price for it.
Tags: 2014, Midwest, 2013, Washington University, WashU, BioResearch Product Faire Event, MO, St Louis, laboratory equipment, Dictyostelium discoideum
With this winter's epic flu invasion maxing out emergency room space and leaving pharmacies without enough flu vaccine, influenza research is a hot topic in the news. Inquiring minds want to know: when will we have the tools to put this mutating foe out of commission once and for all? One very interesting approach to the problem of outsmarting the flu virus involves disrupting its timing by altering a critical protein it needs to exit the cell. At Mount Sinai School of Medicine in New York, microbiologist and virologist Benjamin R. tenOever recently published an article on his lab research into the molecular basis of virus pathogenicity in the journal Cell Reports. He was also interviewed by NPR just last week for their shots health news program, where he described the carefully-orchestrated maneuvering of the flu virus both into and out of the host cell by likening it to a bank robbery. If one part of the plan doesn't go off like clockwork, the gig is up.
Tags: 2014, Mount Sinai School of Medicine, 2013, Northeast, Virology, influenza research, New York, MSSM, BioResearch Product Faire Event, NY, New York City, Life Science Technology, lab supplier, Mt. Sinai

